1
|
Mukherjee T, Yadav J, Nathan N, Tsang D, Yan A, Cash S, Cummins C, Vlachou P, Girardin S, Philpott D. A5 A MOUSE MODEL TO UNRAVEL THE PATHOPHYSIOLOGICAL LINK BETWEEN CROHN’S DISEASE AND TYPE-2 DIABETES-ASSOCIATED METABOLIC DISORDERS. J Can Assoc Gastroenterol 2023. [PMCID: PMC9991282 DOI: 10.1093/jcag/gwac036.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/09/2023] Open
Abstract
Background Crohn’s disease (CD), an idiopathic inflammatory bowel disease (IBD), has been recently shown to increase the risk of developing type 2 diabetes (T2D). Moreover, treatment with anti-diabetic drugs has a protective role in preventing the severity and course of CD progression. However, the pathophysiological basis of T2D development in CD remains unclear. Findings have highlighted the contribution of adipose tissue (AT) to the development of chronic inflammatory diseases and have identified parallels between T2D and CD that may provide hints to common mechanisms of disease pathogenesis. Typically, microbial dysbiosis, hyperpermeable intestinal barrier, and intra-abdominal AT accumulation are the common features of both diseases, yet how the interplay of these factors contribute to pathogenesis is not known. Therefore, common pathogenic paradigms underlying both T2D and CD have led us to hypothesize that chronic intestinal inflammation serves as an initiator of AT dysfunction in CD, predisposing individuals to T2D. Further, the lack of appropriate animal models of CD with chronic intestinal inflammation that manifests accumulation of intra-abdominal AT, and extra-intestinal metabolic disorder as observed in CD and T2D patients has been a limitation. Purpose To develop a genetic mouse model to investigate if gut inflammation-mediated microbial dysbiosis and metabolic dysregulation of AT are at the nexus that cause T2D in CD. Method We developed a CD-mouse model, where we challenged Nod2-deficient mice (NOD2 being the strongest genetic risk factor contributing to CD) with a chronic inflammatory insult regime, using dextran sulfate sodium (cDSS) for 3 cycles. Subsequently, intraperitoneal insulin and oral glucose tolerance tests, metabolic caging, and MRI imaging of mice were performed. Changes in AT metabolism and microbial infiltration into AT were analyzed by quantitative real-time PCR (qRT-PCR) and/or immunohistochemistry (IHC). Result(s) Our new CD-mouse model revealed increased gut inflammation (TNF and type-I IFN) in Nod2-deficient mice compared to wild-type control mice post-cDSS. Surprisingly, Nod2-deficient mice gained body weight, which was at least in part accounted for by an increased intra-abdominal AT accumulation along with decreased AT fatty-acid metabolism (Cpt1a, Fabp4 expression) and AT browning (Ucp1, Cidea expression, and UCP-1 staining), reduced intestinal goblet cell numbers, increased gut bacterial infiltration within the fat, more insulin resistance and energy expenditure. Conclusion(s) This experimental mouse model mimicking CD-associated T2D will provide insights into how the microbiome-AT axis fuel chronic inflammation-mediated extra-intestinal metabolic disorder and immune dysregulation. Understanding these connections will be transformative, as it will help us devise novel therapeutic strategies to prevent T2D development in progressive CD patients. Disclosure of Interest None Declared
Collapse
Affiliation(s)
- T Mukherjee
- Department of Immunology/ Laboratory Medicine and Pathobiology
| | | | | | | | - A Yan
- Department of Pharmaceutical Sciences
| | - S Cash
- Department of Pharmaceutical Sciences
| | - C Cummins
- Department of Pharmaceutical Sciences
| | - P Vlachou
- Department of Medical Imaging, University of Toronto, Toronto, Canada
| | - S Girardin
- Department of Immunology/ Laboratory Medicine and Pathobiology
| | | |
Collapse
|
3
|
Tsankov B, Carr C, Luchak A, Nathan N, Girardin S, Philpott D. A173 ELUCIDATING THE EFFECTS OF NOD2-MEDIATED SIGNALLING ON INTESTINAL RESIDENT-MEMORY T-CELL FORMATION AND FUNCTION. J Can Assoc Gastroenterol 2023. [PMCID: PMC9991289 DOI: 10.1093/jcag/gwac036.173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/09/2023] Open
Abstract
Background Aberrant resident memory T-cell (TRM) responses have been associated with increased intestinal inflammation and Crohn’s disease (CD) pathology in humans. Intestinal TRM cells are not only important for maintaining the integrity of the intestinal epithelial barrier, but also for the rapid clearance of pathogens in the intestine during infection. Understanding the signals received by the intestinal immune system to generate TRM responses is paramount to elucidating treatments for CD. Genetic mutations in NOD2 are associated with the highest risk of CD development. As a host intracellular sensor of bacterial peptidoglycan, NOD2 is critical for initiating both innate and adaptive immune responses. Furthermore, work from our lab as well as those of our collaborators suggest that NOD2 deficiency reduces systemic memory B and T-cell responses. However, the role of NOD2 in establishing memory T-cell responses in the intestine remains unclear. This work will therefore establish the role of NOD2 signaling in initiating and maintaining optimal TRM responses to achieve intestinal homeostasis and resilience to intestinal inflammation. Purpose It is the main objective of this project to determine whether NOD2-mediated signalling affects: 1. Antigen-specific T-cell priming in vivo 2. Bona fide intestinal TRM generation 3. Bona fide intestinal TRM function Method To address the effects of NOD2-signalling on intestinal T-cell priming in vivo, wildtype (WT) mice were adoptively transferred 50,000 naïve LCMV-specific (SMARTA) CD4+ T-cells. Mice were subsequently infected with LCMV-Armstrong in the presence or absence of the NOD2 agonist; MDP. 5-days following infection, the numbers and percentage of LCMV-specific T-cells in the mesenteric lymph nodes and spleen were examined. To examine the effects of NOD2 on intestinal TRM generation, littermate WT and NOD2 KO mice were infected with LCMV-Armstrong. Thirty-six-days following infection, the percentage and number of LCMV-specific CD4+ T-cells were profiled in the small and large intestinal lamina-propria by means of gp66-77 class-II MHC-tetramer staining. In another set of experiments, littermate WT and NOD2 KO mice were re-infected with LCMV-C13 30-days following LCMV-Armstrong immunization, and the interferon-response in the small intestine was profiled by quantitative PCR to assess the effect of NOD2-deficiency on antigen recall responses. Result(s) NOD2-stimulation by means of MDP injection increased the percentage and number of adoptively transferred SMARTA CD4+ T-cells in the mesenteric lymph nodes upon LCMV infection. Furthermore, NOD2-deficiency did not alter intestinal LCMV-specific CD4+ TRM seeding in the small and large intestinal lamina propria 36 days after infection. However, in vivo antigen recall experiments showed a decreased intestinal IFN response in NOD2 KO mice. Conclusion(s) Our findings reveal a potential role of NOD2 in the intestinal CD4+ T-cell priming and subsequent Ag-specific memory response. Disclosure of Interest None Declared
Collapse
Affiliation(s)
| | | | | | | | - S Girardin
- Laboratory Medicine and Pathobiology, Medical Sciences Building, University of Toronto, Toronto, Canada
| | | |
Collapse
|
4
|
Ranger A, Girardin S. A22 USING INTESTINAL ORGANOIDS TO CHARACTERIZE THE NAIP-NLRC4 INFLAMMASOME RESPONSE IN THE INTESTINAL EPITHELIUM. J Can Assoc Gastroenterol 2023. [PMCID: PMC9991125 DOI: 10.1093/jcag/gwac036.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/09/2023] Open
Abstract
Background The NAIP-NLRC4 inflammasome is an important innate defence mechanism in intestinal epithelial cells (IECs) that protects the gut from invasive pathogens. NAIP-NLRC4 activation triggers pyroptotic cell death, releases active interleukin (IL)-18, and promotes the expulsion of infected enterocytes. Dysregulated inflammasomes result in exaggerated inflammation of the intestinal mucosa which is characterisitic of inflammatory bowel disease (IBD). There is increasing evidence that inflammasomes in IEC behave differently than in immune cells. However, a majority of inflammasome pathway characterization is studied immune cells. In addition, NAIP-NLRC4 activity in macrophages has been shown to be important for regulating the expression of nitric oxide (Nos2). The potential transcriptomic impact of NAIP-NLRC4 activity in IECs has yet to be explored. Purpose We will use intestinal orgnaoids to systematically characterize the NAIP-NLRC4 inflammasome pathway and identify the transcriptomic impact of NAIP-NLRC4 activity in IECs. To better define the role of NAIP-NLRC4 activity during a physiological infection, we have developed a novel ex vivo model of Shigella infection in 3D organoids. Method Organoids were derived from the ileal crypts of wild type (WT) and Nlrc4-/-, Casp1-/-, Pycard-/-, or Tlr5-/- mice and stimulated with Pam3CSk4, LPS, or flagellin. Inflammasome activation was assessed by Western blot (WB) and propidium iodide uptake. WT and Nlrc4-/- organoids were infected with WT or a non-invasive Shigella mutant and the inflammasome response was evaluated by WB and a colony forming unit assay. WT and Nlrc4-/- organoids were stimulated with flagellin and gene expression was assessed by RT-qPCR. Result(s) Basolateral organoid stimulation with bacterial ligands revealed a novel response of IECs to bacterial flagellin that results in pyroptosis and IL-18 processing. Basolateral internalization of flagellin occurred in a TLR5-independent manner. Inflammasome activation by flagellin was fully abrogated in Nlrc4-/- and Casp1-/- organoids while only IL-18 processing was affected in Pycard-/- organoids. Infection with only WT Shigella induced inflammasome activation in an NLRC4-dependent manner. Interestingly, flagellin stimulation of WT but not Nlrc4-/- organoids led to increased expression of Nos2. Furthermore, Nlrc4-/- organoids had significantly lower expression levels of cytokine genes Ccl20, Cxcl1, and Tnf following inflammasome activation. Conclusion(s) Our study demonstrates an integral role for epithelial NAIP-NLRC4 inflammasomes in the response to bacterial flagellin and Shigella infection. We have uncovered a novel response of IECs to basolateral flagellin stimulation and revealed that NAIP-NLRC4 is important for the transcriptional regulation of inflammatory genes. Further work will examine how NAIP-NLRC4 activation controls inflammation and epithelial integrity by analyzing the NLRC4-dependent transcriptome and the effects on cell proliferation, differentiation, and barrier integrity. Please acknowledge all funding agencies by checking the applicable boxes below CCC, CIHR Disclosure of Interest None Declared
Collapse
Affiliation(s)
- A Ranger
- Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
| | - S Girardin
- Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
| |
Collapse
|
6
|
Raju D, Hussey S, Ang M, Terebiznik M, Sibony M, Galindo-Mata E, Gupta V, Blanke S, Delgado A, Romero-Gallo J, Ramjeet M, Mascarenhas H, Peek R, Correa P, Streutker C, Hold G, Kunstmann E, Yoshimori T, Silverberg MS, Girardin S, Philpott D, El Omar E, Jones N. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 2012; 142:1160-71. [PMID: 22333951 PMCID: PMC3336037 DOI: 10.1053/j.gastro.2012.01.043] [Citation(s) in RCA: 162] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2011] [Revised: 01/03/2012] [Accepted: 01/26/2012] [Indexed: 02/07/2023]
Abstract
BACKGROUND & AIMS The Helicobacter pylori toxin vacuolating cytotoxin (VacA) promotes gastric colonization, and its presence (VacA(+)) is associated with more-severe disease. The exact mechanisms by which VacA contributes to infection are unclear. We previously found that limited exposure to VacA induces autophagy of gastric cells, which eliminates the toxin; we investigated whether autophagy serves as a defense mechanism against H pylori infection. METHODS We investigated the effect of VacA on autophagy in human gastric epithelial cells and primary gastric cells from mice. Expression of p62, a marker of autophagy, was also assessed in gastric tissues from patients infected with toxigenic (VacA(+)) or nontoxigenic strains. We analyzed the effect of VacA on autophagy in peripheral blood monocytes obtained from subjects with different genotypes of ATG16L1, which regulates autophagy. We performed genotyping for ATG16L1 in 2 cohorts of infected and uninfected subjects. RESULTS Prolonged exposure of human gastric epithelial cells and mouse gastric cells to VacA disrupted induction of autophagy in response to the toxin, because the cells lacked cathepsin D in autophagosomes. Loss of autophagy resulted in the accumulation of p62 and reactive oxygen species. Gastric biopsy samples from patients infected with VacA(+), but not nontoxigenic strains of H pylori, had increased levels of p62. Peripheral blood monocytes isolated from individuals with polymorphisms in ATG16L1 that increase susceptibility to Crohn's disease had reduced induction of autophagy in response to VacA(+) compared to cells from individuals that did not have these polymorphisms. The presence of the ATG16L1 Crohn's disease risk variant increased susceptibility to H pylori infection in 2 separate cohorts. CONCLUSIONS Autophagy protects against infection with H pylori; the toxin VacA disrupts autophagy to promote infection, which could contribute to inflammation and eventual carcinogenesis.
Collapse
Affiliation(s)
- D Raju
- Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada, Departments of Paediatrics and Physiology, University of Toronto, Toronto, ON, Canada
| | - S Hussey
- Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada, Departments of Paediatrics and Physiology, University of Toronto, Toronto, ON, Canada,Department of Immunology, University of Toronto, Toronto, ON Canada
| | - M Ang
- Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada, Departments of Paediatrics and Physiology, University of Toronto, Toronto, ON, Canada
| | - M.R. Terebiznik
- Department of Cell and Systems Biology, University of Toronto, Scarborough, ON, Canada
| | - M Sibony
- Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada, Departments of Paediatrics and Physiology, University of Toronto, Toronto, ON, Canada,Zane Cohen Centre for Digestive Diseases, IBD group, Mount Sinai Hospital, Toronto, ON
| | - E Galindo-Mata
- Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada, Departments of Paediatrics and Physiology, University of Toronto, Toronto, ON, Canada
| | - V Gupta
- Department of Microbiology and Institute for Genomic Biology, University of Illinois, Urbana, IL, USA
| | - S.R. Blanke
- Department of Microbiology and Institute for Genomic Biology, University of Illinois, Urbana, IL, USA
| | - A Delgado
- Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Centre, Nashville, TN
| | - J Romero-Gallo
- Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Centre, Nashville, TN
| | - M Ramjeet
- Department of Laboratory Medicine and Pathobiology, and the Li Ka Shing Knowledge Institute University of Toronto, Toronto, ON
| | - H Mascarenhas
- Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada, Departments of Paediatrics and Physiology, University of Toronto, Toronto, ON, Canada,Department of Immunology, University of Toronto, Toronto, ON Canada
| | - R.M. Peek
- Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Centre, Nashville, TN
| | - P Correa
- Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Centre, Nashville, TN
| | - C Streutker
- Department of Laboratory Medicine, St. Michaels’s Hospital, Toronto, ON
| | - G Hold
- Institute of Medical Sciences, School of Medicine and Dentistry, Aberdeen University, Foresterhill, Aberdeen
| | - E Kunstmann
- Praxis fur Humangenetik, Theodore-Boveri-Weg, University Wuerzburg, Germany
| | - T Yoshimori
- Department of Cellular Regulation, Research institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan
| | - M. S. Silverberg
- Zane Cohen Centre for Digestive Diseases, IBD group, Mount Sinai Hospital, Toronto, ON
| | - S.E. Girardin
- Department of Laboratory Medicine and Pathobiology, and the Li Ka Shing Knowledge Institute University of Toronto, Toronto, ON
| | - D.J. Philpott
- Department of Immunology, University of Toronto, Toronto, ON Canada
| | - E El Omar
- Institute of Medical Sciences, School of Medicine and Dentistry, Aberdeen University, Foresterhill, Aberdeen
| | - N.L. Jones
- Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada, Departments of Paediatrics and Physiology, University of Toronto, Toronto, ON, Canada,Corresponding Author Dr. Nicola Jones, Departments of Paediatrics and Physiology, University of Toronto, Cell Biology Program, Hospital for Sick Children, 555, University Avenue, Toronto, ON M5G1X8, Phone no: 416-813-7072,
| |
Collapse
|